TrialJournal of psychiatry & neuroscience : JPN2014

Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study.

David Bakish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.